Impact of 18-fluorodeoxyglucose positron emission tomography on computed tomography defined target volumes in radiation treatment planning of esophageal cancer: reduction in geographic misses with equal inter-observer variability

Diseases of the Esophagus

Volumn 23, Issue 6, 2010, Pages 493-501

  Schreurs, L M A ^a   Busz, D M ^a   Paardekooper, G M R M ^a   Beukema, J C ^a   Jager, P L ^a   Van der Jagt, E J ^a   van Dam, G M ^a   Groen, H ^a   Plukker, J T M ^a   Langendijk, J A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Esophageal cancer; FDG PET CT; Radiotherapy; Volume definition

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SIZE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; ESOPHAGUS CANCER; FEMALE; HUMAN; MALE; PHYSICIAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ESOPHAGEAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; OBSERVER VARIATION; POSITRON-EMISSION TOMOGRAPHY; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; RADIOPHARMACEUTICALS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77956009133     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2009.01044.x     Document Type: Article

References (22)

1. Bedenne L, Michel P, Bouche O. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 2007, 25:1160-68.
2. Font A, Arellano A, Fernandez-Llamazares J. Weekly docetaxel with concomitant radiotherapy in patients with inoperable oesophageal cancer. Clin Transl Oncol 2007, 9:177-82.
3. Stahl M, Stuschke M, Lehmann N. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 2005, 23:2310-17.
4. Leong T, Everitt C, Yuen K. A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer. Radiother Oncol 2006, 78:254-61.
5. Townsend D W, Beyer T, Blodgett T M. PET/CT scanners: a hardware approach to image fusion. Semin Nucl Med 2003, 33:193-204.
6. Rasanen J V, Sihvo E I T, Knuuti M J. Prospective analysis of accuracy of positron emission tomography, computed tomography, and endoscopic ultrasonography in staging of adenocarcinoma of the esophagus and the esophagogastric junction. Ann Surg Oncol 2003, 10:954-60.
7. Van Westreenen H L, Heeren P A M, van Dullemen H M. Positron emission tomography with F-18-fluorodeoxyglucose in a combined staging strategy of esophageal cancer prevents unnecessary surgical explorations. J Gastrointest Surg 2005, 9:54-61.
8. Luketich J D, Schauer P R, Meltzer C C. Role of positron emission tomography in staging esophageal cancer. Ann Thorac Surg 1997, 64:765-9.
9. Ciernik I F, Dizendorf E, Baumert B G. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study. Int J Radiat Oncol Biol Phys 2003, 57:853-63.
10. Sobin L H, Fleming I D. TNM classification of malignant tumors, fifth edition (1997). Cancer 1997, 80:1803-4.
11. Lonneux M, Borbath I, Bol A. Attenuation correction in whole-body FDG oncological studies: the role of statistical reconstruction. Eur J Nucl Med 1999, 26:591-8.
12. Nestle U, Kremp S, Schaefer-Schuler A. Comparison of different methods for delineation of F-18-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-small cell lung cancer. J Nucl Med 2005, 46:1342-8.
13. Greco C, Rosenzweig K, Cascini G L, Tamburrini O. Current status of PET/CT for tumour volume definition in radiotherapy treatment planning for non-small cell lung cancer (NSCLC). Lung Cancer 2007
14. Ashamalla H, Rafla S, Parikh K. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer. Int J Radiat Oncol Biol Phys 2005, 63:1016-23.
15. Van Baardwijk A, Baumert B G, Bosmans G. The current status of FDG-PET in tumour volume definition in radiotherapy treatment planning. Cancer Treat Rev 2006, 32:245-60.
16. Mac Manus M, Nestle U, Rosenzweig K E. Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006-2007. Radiother Oncol 2009, 91:85-94.
17. Hong T S, Killoran J H, Mamede M, Mamon H J. Impact of manual and automated interpretation of fused PET/CT data on esophageal target definitions in radiation planning. Int J Radiat Oncol Biol Phys 2008, 72:1612-18.
18. Gondi V, Bradley K, Mehta M. Impact of hybrid fluorodeoxyglucose positron-emission tomography/computed tomography on radiotherapy planning in esophageal and non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2007, 67:187-95.
19. Konski A, Doss M, Milestone B. The integration of 18-fluoro-deoxy-glucose positron emission tomography and endoscopic ultrasound in the treatment-planning process for esophageal carcinoma. Int J Radiat Oncol Biol Phys 2005, 61:1123-8.
20. Moureau-Zabotto L, Touboul E, Lerouge D. Impact of CT and F-18-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma. Int J Radiat Oncol Biol Phys 2005, 63:340-45.
21. Zhong X, Yu J, Zhang B. Using 18F-fluorodeoxyglucose positron emission tomography to estimate the length of gross tumor in patients with squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 2009, 73:136-41.
22. Geets X, Daisne J F, Gregoire V, Hamoir M, Lonneux M. Role of 11-C-methionine positron emission tomography for the delineation of the tumor volume in pharyngo-laryngeal squamous cell carcinoma: comparison with FDG-PET and CT. Radiother Oncol 2004, 71:267-73.